DK149988D0 - Stabile farmaceutiske praeparater - Google Patents

Stabile farmaceutiske praeparater

Info

Publication number
DK149988D0
DK149988D0 DK149988A DK149988A DK149988D0 DK 149988 D0 DK149988 D0 DK 149988D0 DK 149988 A DK149988 A DK 149988A DK 149988 A DK149988 A DK 149988A DK 149988 D0 DK149988 D0 DK 149988D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
stable pharmaceutical
stable
preparations
pharmaceutical
Prior art date
Application number
DK149988A
Other languages
English (en)
Other versions
DK149988A (da
Inventor
Brian Anthony Christoph Carlin
John Norman Charles Healey
Graham Stanley Leonard
Geoffrey David Tovey
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DK149988D0 publication Critical patent/DK149988D0/da
Publication of DK149988A publication Critical patent/DK149988A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK149988A 1986-08-01 1988-03-18 Stabile farmaceutiske praeparater DK149988A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868618847A GB8618847D0 (en) 1986-08-01 1986-08-01 Pharmaceutical formulations
PCT/GB1987/000539 WO1988000825A1 (en) 1986-08-01 1987-07-29 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
DK149988D0 true DK149988D0 (da) 1988-03-18
DK149988A DK149988A (da) 1988-03-18

Family

ID=10602097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK149988A DK149988A (da) 1986-08-01 1988-03-18 Stabile farmaceutiske praeparater

Country Status (22)

Country Link
US (1) US4996222A (da)
EP (1) EP0257823B1 (da)
JP (1) JPH0643304B2 (da)
KR (1) KR960012397B1 (da)
CN (1) CN1024497C (da)
AU (1) AU601206B2 (da)
CA (1) CA1287802C (da)
DE (1) DE3778795D1 (da)
DK (1) DK149988A (da)
EG (1) EG18388A (da)
ES (1) ES2037086T3 (da)
GB (1) GB8618847D0 (da)
GR (1) GR3005298T3 (da)
HU (1) HU205853B (da)
IE (1) IE60759B1 (da)
IL (1) IL83349A (da)
MY (1) MY100998A (da)
PH (1) PH23505A (da)
PT (1) PT85468B (da)
WO (1) WO1988000825A1 (da)
ZA (1) ZA875631B (da)
ZW (1) ZW13587A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
GB2222772B (en) * 1988-09-20 1992-05-13 Glaxo Group Ltd Pharmaceutical compositions
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
AU3154895A (en) * 1994-08-01 1996-03-04 Kv Pharmaceutical Corporation Tastemasked liquid pharmaceutical delivery system
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB2298365B (en) * 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
CN1197584C (zh) * 1997-04-30 2005-04-20 雷克特本克斯尔保健(英国)有限公司 可倾倒的藻酸盐组合物
IN186245B (da) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US6515008B1 (en) * 2000-05-04 2003-02-04 Smithkline Beecham Corporation Formulation
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
US6930119B2 (en) * 2002-07-17 2005-08-16 Reliant Pharmaceuticals, Inc. Liquid pharmaceutical composition
WO2004080343A2 (en) * 2003-03-10 2004-09-23 The Regents Of The University Of Michigan Compositions and methods for use of alginate dural sealants
EP1811854A1 (en) * 2004-11-02 2007-08-01 PURAC Biochem BV Method for stabilizing and preventing coagulation of proteins in milk
US20060094760A1 (en) * 2004-11-04 2006-05-04 Fawzy Abdel A Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) * 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
MX2012002831A (es) * 2009-09-10 2012-05-08 Bial Portela & Ca Sa Formulaciones para suspension oral de acetato de esclicarbazepina.
WO2018075801A1 (en) * 2016-10-19 2018-04-26 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies
GB201918617D0 (en) * 2019-12-17 2020-01-29 Reckitt Benckiser Health Ltd Personal lubricant composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104868A (en) * 1980-01-24 1981-08-20 Fujimoto Seiyaku Kk Conversion between polymorphous crystals of cimetidine
HU185457B (en) * 1981-09-25 1985-02-28 Richter Gedeon Vegyeszet Process for preparating cimetidine-z
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
EP0257823A1 (en) 1988-03-02
ZA875631B (en) 1989-03-29
PH23505A (en) 1989-08-16
HU205853B (en) 1992-07-28
IE60759B1 (en) 1994-08-10
IE872077L (en) 1988-02-01
ZW13587A1 (en) 1989-02-15
KR880701551A (ko) 1988-11-03
HUT46541A (en) 1988-11-28
AU601206B2 (en) 1990-09-06
MY100998A (en) 1991-06-29
CN87105387A (zh) 1988-02-17
JPH01500434A (ja) 1989-02-16
EP0257823B1 (en) 1992-05-06
IL83349A (en) 1992-03-29
AU7756487A (en) 1988-02-24
DE3778795D1 (de) 1992-06-11
EG18388A (en) 1992-10-30
CA1287802C (en) 1991-08-20
US4996222A (en) 1991-02-26
DK149988A (da) 1988-03-18
JPH0643304B2 (ja) 1994-06-08
GB8618847D0 (en) 1986-09-10
KR960012397B1 (ko) 1996-09-20
WO1988000825A1 (en) 1988-02-11
PT85468A (en) 1987-08-01
PT85468B (pt) 1990-06-29
GR3005298T3 (da) 1993-05-24
CN1024497C (zh) 1994-05-18
ES2037086T3 (es) 1993-06-16

Similar Documents

Publication Publication Date Title
DK149988D0 (da) Stabile farmaceutiske praeparater
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
NO922005D0 (no) Farmasoeytiske preparater
DK546886D0 (da) Farmaceutisk praeparat
DK413987D0 (da) Farmaceutiske praeparater
DK184087D0 (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
DK237187A (da) Farmaceutisk anvendelse af t-pa
DK259186D0 (da) Nasale farmaceutiske praeparater
DK652787A (da) Farmaceutiske praeparater
DK288686D0 (da) Farmaceutiske praeparater
DK133786D0 (da) Praeparater
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
MX172943B (es) Formulacion farmaceutica
DK24986A (da) Allergenholdige praeparater
DK401387D0 (da) Benzopyranderivatholdige praeparater
DK447887D0 (da) Frysetoerrede farmaceutiske praeparater
DK142487D0 (da) Farmaceutiske midler
DK139388A (da) Farmaceutisk praeparat
DK276288A (da) Farmaceutisk praeparat
DK503386D0 (da) Peptidpraeparater
DK466086A (da) Exogent syrnede antacidiumpraeparater
DK149588D0 (da) Xylometazolinholdige farmaceutiske praeparater
DK138888A (da) Farmaceutisk praeparat
DK428287D0 (da) Nasalt farmaceutisk praeparat
SE8504793D0 (sv) Pharmaceutical preparations

Legal Events

Date Code Title Description
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment